Shareholders Approve N1.00 Dividend per 50 kobo ordinary shares and N30 Billion Capital Raise Mandate at a Landmark Virtual AGM LAGOS, NIGERIA – August 1, 2025 Fidson Healthcare Plc (the
Nigeria’s leading pharmaceutical company, Fidson Healthcare Plc announces the appointment of three new Directors. This strategic move, made by the Board, at a meeting which held in December, 2024, underscores
Yes! We have won it again for the 4th consecutive time! We also emerged the 1st runner-up for the Overall Employer of the Year! 🥳🥳🥳This affirms our collective dedication to
Fidson Healthcare Plc, Nigeria’s foFidson Healthcare Plc, the leading Nigerian pharmaceutical company signed a Strategic Cooperation Memorandum with Jiangsu Aidea Pharma, Nanjing PharmaBlock, and the China-Africa Development Fund in Beijing,
Fidson Healthcare Plc, Nigeria’s foremost pharmaceutical company, today announced a strategic partnership with Liddie BE Ltd, a renowned Clinical Research Organization, to conduct a Bioequivalence (BE) study on their chewable
Fidson Healthcare is thrilled to announce that we have been honored with two prestigious accolades at the Nigerian Health Excellence Awards (NHEA) 2024, held at the Convention Centre, Eko Hotel
The Financial Times, (FT) London has recognized Fidson Healthcare Plc, the leading pharmaceutical company in Nigeria as one of the fastest-growing companies in Africa. In the 2024 ranking of Africa’s
FIDSON HEALTHCARE ANNOUNCES STRATEGIC COOPERATION WITH A LEADING CHINESE PHARMACEUTICAL COMPANY In a bid to further add value to the healthcare landscape in Nigeria and Africa, Fidson Healthcare Plc (Fidson),
In a bid to guarantee the seamless supply of its products across the country in a way that provides all stakeholders in the value chain the opportunity for sustainable business
Fidson Healthcare Plc held the 12th edition of the Astymin Brilliance Reward event on Saturday, August 27, 2022, at the company’s Head Office in Lagos. The hybrid event, which is
